NorthStar Cryo

NorthStar Cryo believes that disruptive innovation in cryopreservation will unlock the potential of regenerative cell therapy. CryoMesh, our core platform for vitrification of cellular systems, enables effective deployment of game-changing and life altering cell therapies at the right time, in the right place and in the right quantity. Learn more about the science behind and the potential of CryoMesh in these publications: ● Pancreatic islet cryopreservation by vitrification achieves high viability, function, recovery and clinical scalability for transplantation – Zhan et al., Nature Medicine, Vol. 28, pages 798–808 (2022) ● Conduction-Dominated Cryomesh for Organism Vitrification – Guo et al., Advanced Science, Vol 11, Issue 3 (2024) ● Cryopreservation methods for Drosophila melanogaster embryos – Nature Communications, 12, Article number: 2412 (2021) ● Vitrification and nanowarming enable long-term cryopreservation and life-sustaining kidney transplantation in a rat model – Han et al., Nature Communications, Vol. 14, Article number: 3407 (2023)